Incidence, management and outcomes of the first cfr-mediated linezolid-resistant Staphylococcus epidermidis outbreak in a tertiary referral centre in the Republic of Ireland.
posted on 2023-03-08, 10:04authored byJames Powell, Cathriona Finnegan, A. O'Gorman, Barrett S., K.L. Hopkins, B. Pichon, R. Hill, Lorraine Power, Neil Woodford, Calvin J. Coffey, A. Kearns, Nuala H. O'Connell, Colum P. DunneColum P. Dunne, Ciara O'Connor
Aim: To report the first Irish outbreak of cfr-mediated linezolid-resistant Staphylococcus
epidermidis.
Methods: Linezolid-resistant S. epidermidis isolated at University Hospital Limerick from
four blood cultures, one wound and four screening swabs (from nine patients) between
April and June 2013 were characterized by pulsed-field gel electrophoresis (PFGE), multilocus
sequence typing (MLST) and staphylococcal cassette chromosome (SCCmec) typing.
Antibiotic susceptibilities were determined according to the guidelines of the British Society
for Antimicrobial Chemotherapy. The outbreak was controlled through prohibiting
prescription and use of linezolid, adherence to infection prevention and control practices,
enhanced environmental cleaning, isolation of affected patients, and hospital-wide education
programmes.
Findings: PFGE showed that all nine isolates represented a single clonal strain. MLST
showed that they belonged to ST2, and SCCmec typing showed that they encoded a variant
of SCCmecIII. All nine isolates were cfr positive, and eight isolates were positive for the
G2576T 23S rRNA mutation commonly associated with linezolid resistance. Isolates
exhibited multiple antibiotic resistances (i.e. linezolid, gentamicin, methicillin, clindamycin,
ciprofloxacin, fusidic acid and rifampicin). The adopted infection prevention
intervention was effective, and the outbreak was limited to the affected intensive care
unit.